International Track 200

This Birmingham-based manufacturer supplies 35m tests a year to diagnose and monitor blood cancers and immune system disorders. It has also developed a Covid-19 antibody test in collaboration with the city’s university. The company has a direct presence in more than 25 countries and 3,000 customers in over 100 countries. More than 90% of sales are generated overseas and exports reached £139.1m in the year to September 2020. The business is led by chief executive Charles de Rohan, 59, and owned by private equity firm Nordic Capital.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyThe Binding Site
ActivityDiagnostics test manufacturer
Intl sales £000s*139,071
Total sales £000s*150,153

If applicable:

* supplied by company